now browsing by category
We live at a time when medical breakthroughs are being made almost weekly. The fight against all forms of cancer is being taken on by many pharmaceutical companies. The treatment methodology has added targeted chemotherapy to the basic treatment of radiation and traditional chemotherapy. These exciting new therapies may, in the not too distant future, provide ways to treat and possibly cure many types of cancer.
One such company making huge strides in cancer treatment is Seattle Genetics. Founded in 1998, its CEO Dr. Clay Siegall has driven his company to excel in new technology. Dr. Siegal is driven by an intense desire to help cancer patients and has made it a priority for his company to concentrate on research and quickly implement any medical breakthroughs.
Dr, Siegall worked for the National Cancer Institute from 1988 to 1991, and then became a Senior Research Investigator for Bristol-Myers Squibb. He soon was promoted to Principal Scientist, and then became a Staff Fellow and Biotechnology Fellow at the National Cancer Institute. In addition to leading Seattle Genetics, Dr. Siegall has more than 70 published scientific articles and 15 patents to his credit.
Under his tutelage, in 2011 the company received FDA approval for the first antibody-drug conjugate (ADCs) ADCETRIS and is now available to patients in 60 countries. In 2016, the FDA granted Breakthrough Therapy Designation for another antibody-drug conjugate, sacituzumab govitecan (try saying that three times fast). This wonder drug is being tested for treatment of a number of cancers, including lung, breast, bladder and pancreatic cancer.
With many new antibody-based cancer therapies in their pipeline, Dr. Siegall may soon realize his dream of conquering cancer.
As one would know, there are many different types of cancer that one can come down with. Some of them have an effect on men only, or women only. Then there are the types of cancer that can affect both genders evenly. However, it may be surprising to know the many different types of cancer that one can get. However, as one learns about the different forms of cancer, they will also learn about the risk factors involves and the ways to prevent it. The best way to learn about this is through information gathered from a good source that is exhaustive in information about cancer.
According to Wikipedia, one good source of information that people can go to is Cancer Treatment Centers of America. There are tons of different types of cancer that are listed on the site. One good thing about this company is that if there are any new discoveries in the cancer realm, this is one of the first sites to upload this information. Cancer Treatment Centers of America does not waste any time when it comes to handling cancer. They understand that time is of the essence for people who have this condition because they could eventually die from the cancer.
Among the different forms of cancer that people can be affected with are brain cancer, leukemia, breast cancer, bladder cancer, prostate cancer, and plenty of other forms of cancer. Some of the forms of cancer are harder to treat than others. One reason is that they are hard to detect. Fortunately, Cancer Treatment Centers of America is willing to help with the avoidance of cancer as well because they understand that even the treatment of cancer can be very devastating to the individual. Chemotherapy does cause a lot of issue in the body that needs to be treated with other medications.
For more information on CTCA follow them on Facebook.
There are a lot of issues that come with cancer. One thing that people who have gained cancer are going to be faced with are a ton of issues. For one thing, people are going to have a lot of questions. However, they may not be able to ask it all at once because the news that they have cancer can come as a serious blow to their way of life. Fortunately, there is a place where they could get answers. This place is called Cancer Treatment Centers of America. This place is the one database that contains information not only about cancer, but also the treatment.
According to the article, “Cancer Treatment Centers of America® Partners with Allscripts and NantHealth to Launch Clinical Pathways, a Comprehensive and Custom Oncology Treatment Platform,” CTCA also offers people many options for care as they go through the different stages. Of course when they are given the diagnosis, they are going to want to know what they are looking at. With CTCA, they are able to get all of the information of what could possibly happen. For instance, they may get information as to if they are going to need surgery after chemotherapy. At the same time, the professionals at Cancer Treatment Centers of America are willing to find someone with the answers if they themselves do not have the answers that are needed.
CCA has proven itself to be one of the powerhouses of cancer treatment. This is one of the reasons that many other medical facilities and institutions are willing to team up with CTCA. Among the partnerships that CTCA has formed are those with NantHealth and AllScripts. Therefore, they will get even more assistance with finding more effective treatments for cancer. People will also be able to do some research for themselves on the disease that is affecting many people in the world. For those that do not have cancer yet, there are things that can be done to prevent the occurrence of the disease.
At the helm of the leading innovative, antibody-drug conjugates biotechnology firm in the nation, is Clay B. Siegall, Ph.D. Siegall co-founded Seattle Genetics in 1998. Aside from the title of President, he also holds the positions of Chairman of the Board and Chief Executive Officer.
The focus of Seattle Genetics is on cancer antibody treatments and therapies. The treatments and therapies, known as antibody-drug conjugates (ADCs). ADC’s captures a monoclonal antibody’s targeting mechanism and produces producing cancer destroying elements to cells afflicted with cancer. ADC’s target only cancer cells and avoid non-cancerous cells. This process dramatically lowers the toxicity from chemotherapy and possibly enhances anti-tumor development. Seattle Genetics innovative technology fulfills the need for life-threatening solutions.
CEO, President, and Chairman of the Board, Clay B. Siegall career trained him as a scientist. His curiosity with a cure for cancer leads him to form Seattle Genetics. Seattle Genetics dedication towards contemporary innovation, determined research, and pharmaceutical drug development makes it a leader in the cancer biotechnology sector.
Dr.Siegall spearheaded Seattle Genetic’s successful 2011 effort in obtaining the United States Food and Drug Administration’s approval of ADCETRIS® (brentuximab vedotin). He worked closely with the Takeda Pharmaceutical Company, overseeing a joint marketing agreement and distribution effort. The agreement makes ADCETRIS the leading brand worldwide for cancer treatments. So successful is the product, 60 governmental authorities around the world have approved its use. As a result of its success, Seattle Genetics is establishing a vast array of proprietary ADC cancer treatments.
Seattle Genetic’s success in research technology of ADC’s enabled it to sign numerous strategic production and marketing licenses with Pfizer, Genentech (Roche), GlaxoSmithKline and AbbVie. These collaborative agreements brought Seattle Genetics over $325 million. With over 20 ADC’s in development, Dr. Siegall’s efforts have increased the firm’s capital income, securing more than $1.2 billion in public offerings and private and public solicitations.
More information about Dr. Clay B. Siegall, Ph.D. and Seattle Genetics is available at their website, http://www.seattlegenetics.com/